All News

A tale of two cities: as the industry in Lyon trumpeted the benefits of biotech, MEPs in Strasbourg looked the other way, and declined to debate them

2006 was a record year for business start-ups in Ireland.

The Drugs for Neglected Diseases initiative launched its first product, a new formulation of for treating malaria.

The UK’s two major public funders of stem cell research are to run a national public discussion about the controversial field of stem cell research.

The band of UK quoted tech commercialisation companies has another member. Ipso Ventures joined the AIM market, raising £4.5 million.

The value of R&D coming out of US universities is increasing. And the question of exactly how Europe measures up in comparison may soon be answered.